Development of Next-Generation Drugs to Inhibit Ravages of Chronic Inflammation
05 oct. 2020 08h30 HE
|
180 Life Sciences Corp.
NEW YORK, Oct. 05, 2020 (GLOBE NEWSWIRE) -- NetworkNewsAudio – 180 Life Sciences Corp. (NASDAQ: KBLM) announces the availability of a broadcast titled, “Solving One of the Largest Drivers of...